Loading...
The University of Chicago Header Logo
Keywords
Last Name
Institution

Phase I clinical and pharmacogenetic study of weekly TAS-103 in patients with advanced cancer.

Ewesuedo RB, Iyer L, Das S, Koenig A, Mani S, Vogelzang NJ, Schilsky RL, Brenckman W, Ratain MJ. Phase I clinical and pharmacogenetic study of weekly TAS-103 in patients with advanced cancer. J Clin Oncol. 2001 Apr 01; 19(7):2084-90.

View in: PubMed

collapse authors with profiles